Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TXLNGY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC105379426 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
ASPG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZFHX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
B3GALT5-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COL5A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCNJ5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PUM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAGEB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAPGEF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KNDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C1orf228 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIGLEC7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on